ations in the lung. Translation of our understanding of disease pathogenesis into clinical practice will bring us closer to our real goal -improving the lives of our patients and ultimately curing disease. With the publication of this study, IPF patients may someday breathe more easily. 1 
What are CBS sequence motifs?
Alexander Bateman first recognized cystathionine β-synthase (CBS) sequences by looking for internal sequence duplications within proteins of the Methanococcus janaschii genome. These CBS sequences, typically 60 residues in length, occur as tandem pairs in a diversity of proteins, from archaebacteria to eukaryotes (1, 2), including IMP dehydrogenase (IMPDH), whose protein crystal structure shows that CBS sequence pairs form a discrete structural domain (3) termed a Bateman domain (Figure 1 ) (4). Although it is known that mutations in CBS sequences alter the control functions of their parent proteins and cause hereditary diseases (5-7), the precise mechanisms involved were unknown. 
Regulating energy metabolism via AMPK
The metabolic stress-sensing protein kinase AMPK has come to prominence recently for its role in the control of metabolism and gene transcription in response to exercise. It is responsible for regulating multiple metabolic pathways, including glucose transport, glycolysis, fatty acid, cholesterol, and triglyceride synthesis, as well as fatty acid oxidation. In addition, AMPK is activated by the adipocyte-derived hormones adiponectin and leptin together with two important drugs used to treat type 2 diabetes, metformin and rosiglitazone (10, 11) . For these reasons there has recently been intense interest in AMPK as a target for the treatment of obesity, type 2 diabetes, and the metabolic syndrome. AMPK consists of three subunits, a catalytic subunit α, an intracellular targeting subunit β, and a regulatory subunit γ. As mentioned above, the γ subunits contain four copies of the CBS sequences. The γ subunits are encoded by three genes (γ1, γ2, and γ3), and mutation in the γ3 gene CBS sequence-1 causes the common Hampshire pig glycogen storage disease previously termed the RN -(Rendement Napole) mutation (12) . Economically important alleles within the CBS-1 sequence of the γ3 gene have now been found, which confer reduced muscle glycogen and enhanced meat quality (13) . While no corresponding human γ3 mutations have been reported, six families have been identified with mutations in AMPK γ2 (expressed in the heart) that give rise to a cardiac phenotype with WolffParkinson-White syndrome features (14) . Scott et al. (8) have demonstrated that the γ subunit, with its two pairs of CBS sequences, binds two molecules of AMP and that the human mutations in these CBS sequences cause loss of AMP binding. Several earlier studies provided hints that the γ subunits were important for regulation by AMP but did not prove it. Hamilton et al. (15) introduced the equivalent γ3 mutation found in Hampshire pigs into γ1 and rendered the AMPK constitutively active, independent of AMP. Cheung et al. (16) showed that AMP could be chemically cross-linked to the γ subunit. While mutations in AMPK γ2 cause a reduction in AMP binding, Scott et al. (8) found that they do not result in con- stitutively active AMPK, so it is not yet clear how mutations in AMPK γ2 cause the cardiac phenotype.
The crystal structure of IMPDH has allowed 3D modeling of the γ subunit CBS protein sequences by Scott et al. (8) and Adams et al. (4) . A putative AMP-binding pocket comprising Arg-70, His-151, Arg-152, and Arg-171 has been identified in the γ1 subunit CBS-1/CBS-1 sequence pairs (4) . The presence of multiple basic residues in the binding site is also seen in the classical phosphorylase AMP site (17) , the first example of an allosterically regulated enzyme, reported by Cori and Green 60 years ago (18) . Of the important basic residues identified in the γ1 subunit AMP-binding site, Arg-70 corresponds precisely to the site of one of the human γ2 mutations, as well as the Hampshire pig γ3 mutation and the original CBS mutation, D444N (5).
Knowledge of how AMPK binds AMP paves the way for rational drug design of AMPK activators and inhibitors
The binding of AMP to the γ subunit of AMPK influences the activation of AMPK in several ways. Activation of AMPK depends on phosphorylation by the tumor-suppressor protein kinase LKB1, which is mutated in most cancer patients with Peutz-Jeghers syndrome (19, 20) . The binding of AMP makes AMPK a better substrate for LKB1, in addition to making it more resistant to inactivation by phosphatases. The likely link between AMPK and LKB1 in tumor suppression and cell-growth arrest adds yet another dimension to the potential applications of therapeutic drugs based on the γ subunit AMP-binding site. With regard to health promotion, AMPK mediates a number of the benefits of exercise for metabolism and gene transcription, and this suggests that AMPK-activating drugs that target the γ subunit may increase exercise capacity.
The mark of an important discovery is that it changes our way of thinking. There are now well over a thousand known proteins that contain Bateman domains. For many of these proteins we can now begin to hypothesize about how they are regulated by adenosyl metabolites.
